Axa Private Equity Buys Active Ingredient Business

15:26 PM | April 21, 2008 | Esther D’amico

Health and nutrition product firm Atrium (Quebec City) says it has agreed to sell its active ingredient and specialty chemical division to Axa Private Equity (Paris) for $155 million in cash. The deal...